HK1164318A1 - Oxyindole derivatives with motilin receptor agonistic activity - Google Patents

Oxyindole derivatives with motilin receptor agonistic activity

Info

Publication number
HK1164318A1
HK1164318A1 HK12105180.5A HK12105180A HK1164318A1 HK 1164318 A1 HK1164318 A1 HK 1164318A1 HK 12105180 A HK12105180 A HK 12105180A HK 1164318 A1 HK1164318 A1 HK 1164318A1
Authority
HK
Hong Kong
Prior art keywords
agonistic activity
receptor agonistic
motilin receptor
oxyindole derivatives
oxyindole
Prior art date
Application number
HK12105180.5A
Other languages
English (en)
Chinese (zh)
Inventor
Masaki Sudo
Yasuhiro Iwata
Yoshimasa Arano
Madoka Jinno
Masashi Ohmi
Hirohide Noguchi
Original Assignee
Raqualia Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Raqualia Pharma Inc filed Critical Raqualia Pharma Inc
Publication of HK1164318A1 publication Critical patent/HK1164318A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10Laxatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12Antidiuretics, e.g. drugs for diabetes insipidus
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK12105180.5A 2009-02-27 2012-05-28 Oxyindole derivatives with motilin receptor agonistic activity HK1164318A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20243009P 2009-02-27 2009-02-27
US28217309P 2009-12-24 2009-12-24
PCT/JP2010/001368 WO2010098145A1 (en) 2009-02-27 2010-03-01 Oxyindole derivatives with motilin receptor agonistic activity

Publications (1)

Publication Number Publication Date
HK1164318A1 true HK1164318A1 (en) 2012-09-21

Family

ID=42665356

Family Applications (1)

Application Number Title Priority Date Filing Date
HK12105180.5A HK1164318A1 (en) 2009-02-27 2012-05-28 Oxyindole derivatives with motilin receptor agonistic activity

Country Status (12)

Country Link
US (1) US8697877B2 (xx)
EP (1) EP2401268B1 (xx)
JP (1) JP5663743B2 (xx)
KR (1) KR101575703B1 (xx)
CN (1) CN102317280B (xx)
BR (1) BRPI1007962A2 (xx)
CA (1) CA2750699C (xx)
ES (1) ES2547415T3 (xx)
HK (1) HK1164318A1 (xx)
MX (1) MX2011008857A (xx)
RU (1) RU2533116C2 (xx)
WO (1) WO2010098145A1 (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2938341B1 (en) * 2012-12-31 2018-09-05 Sunovion Pharmaceuticals Inc. Heterocyclic compounds and methods of use thereof
CA2927798C (en) * 2013-10-29 2022-03-15 Biomarin Pharmaceutical Inc. N-(1-hydroxy-3-(pyrrolidinyl)propan-2-yl)pyrrolidine-3-carboxamide derivatives as glucosylceramide synthase inhibitors
BR112016028081A2 (pt) * 2014-05-30 2017-08-22 Sphaera Pharma Private Ltd Novos compostos como agentes antituberculares
BR112023025271A2 (pt) * 2021-07-30 2024-02-27 Raqualia Pharma Inc Forma cristalina a e b de sal hcl, composição farmacêutica, formas cristalinas de sal hcl e uso destas, método de tratamento de doenças ou condições mediadas pela atividade do receptor de motilina, processo para preparação da forma cristalina a

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW355711B (en) 1992-11-04 1999-04-11 Chugai Pharmaceutical Co Ltd Erythromycin derivatives
JP3449766B2 (ja) 1993-11-19 2003-09-22 中外製薬株式会社 モチリンアンタゴニスト
US5767118A (en) * 1994-10-26 1998-06-16 Merck & Co., Inc. 4-Heterocyclic peperidines promote release of growth hormone
JP3901239B2 (ja) 1996-03-13 2007-04-04 大正製薬株式会社 アリールアルカン誘導体
US5734012A (en) 1996-05-16 1998-03-31 Ohmeda Pharmaceutical Products Division Inc. Cyclic motilin-like polypeptides with gastrointestinal motor stimulating activity
DE19644195A1 (de) 1996-10-24 1998-04-30 Solvay Pharm Gmbh 10,13,15-Trioxatricyclo[9.2.1.1.·9·.·6·]-pentadecanon-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
WO1998023629A1 (fr) 1996-11-26 1998-06-04 Chugai Seiyaku Kabushiki Kaisha Composes de macrolides comportant une chaine a 13 elements, medicament les contenant et leur procede de preparation
TWI242011B (en) * 1997-03-31 2005-10-21 Eisai Co Ltd 1,4-substituted cyclic amine derivatives
US5972939A (en) 1997-10-28 1999-10-26 Ortho-Mcneil Pharmaceutical, Inc. Cyclopentene derivatives useful as antagonists of the motilin receptor
DE19805822B4 (de) 1998-02-13 2009-02-05 Solvay Pharmaceuticals Gmbh 11-Acetyl-12,13-dioxabicyclo[8.2.1]tridecenon-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US6165985A (en) 1998-02-13 2000-12-26 Solvay Pharmaceuticals Gmbh 11-acetyl-12,13-dioxabicyclo[8.2.1]-tridecenone derivatives, processes for their preparation and pharmaceutical compositions comprising them
AU2001249144A1 (en) 2000-03-13 2001-09-24 Ortho-Mcneil Pharmaceutical, Inc. Novel cyclopentene derivatives useful as antagonists of the motilin receptor
AU2001247357A1 (en) 2000-03-13 2001-09-24 Ortho-Mcneil Pharmaceutical, Inc. Novel cyclobutene derivatives useful as antagonists of the motilin receptor
AU2001250820A1 (en) 2000-03-13 2001-09-24 Ortho-Mcneil Pharmaceutical, Inc. Novel cyclohexene derivatives useful as antagonists of the motilin receptor
US6511980B2 (en) 2000-05-05 2003-01-28 Ortho Mcneil Pharmaceutical, Inc. Substituted diamine derivatives useful as motilin antagonists
ATE308537T1 (de) 2001-05-10 2005-11-15 Solvay Pharm Gmbh Neue 1-amidomethylcarbonyl-piperidinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US7550431B2 (en) 2003-07-31 2009-06-23 Tranzyme Pharma Inc. Spatially-defined macrocycles incorporating peptide bond surrogates
EP2319859B1 (en) 2003-07-31 2013-03-27 Tranzyme Pharma Inc. Spatially-defined macrocyclic compounds useful for drug discovery
US7338954B2 (en) 2003-09-17 2008-03-04 Bristol-Myers Squibb Company Compounds useful as motilin agonists and method
US7262195B2 (en) 2003-09-17 2007-08-28 Bristol-Myers Squibb Company Compounds useful as motilin agonists and method
WO2006011035A1 (en) 2004-07-23 2006-02-02 Glenmark Pharmaceuticals Ltd. Novel dipeptidyl peptidase iv inhibitors; process for their preparation and compositions containing them
JP4130220B1 (ja) * 2005-02-22 2008-08-06 ファイザー株式会社 5ht4受容体アゴニストとしてのオキシインドール誘導体
US7582611B2 (en) 2005-05-24 2009-09-01 Pfizer Inc. Motilide compounds
WO2007007018A1 (en) 2005-07-12 2007-01-18 Glaxo Group Limited Piperazine heteroaryl derivates as gpr38 agonists
EP1907374B1 (en) 2005-07-26 2012-08-22 Glaxo Group Limited Benzylpiperazine derivatives useful for the treatment of gastrointestinal disorders
EP1757290A1 (en) * 2005-08-16 2007-02-28 Zentaris GmbH Novel triazole derivatives as ghrelin analogue ligands of growth hormone secretagogue receptors
CA2655540A1 (en) * 2006-06-28 2008-01-03 Glaxo Group Limited Piperazinyl derivatives useful in the treatment of gpr38 receptor mediated diseases

Also Published As

Publication number Publication date
US20110312933A1 (en) 2011-12-22
CA2750699C (en) 2015-12-29
CN102317280A (zh) 2012-01-11
ES2547415T3 (es) 2015-10-06
JP5663743B2 (ja) 2015-02-04
WO2010098145A1 (en) 2010-09-02
KR101575703B1 (ko) 2015-12-10
KR20110133033A (ko) 2011-12-09
CA2750699A1 (en) 2010-09-02
CN102317280B (zh) 2014-07-23
MX2011008857A (es) 2011-09-30
BRPI1007962A2 (pt) 2016-02-23
JP2012519153A (ja) 2012-08-23
EP2401268B1 (en) 2015-07-29
EP2401268A1 (en) 2012-01-04
US8697877B2 (en) 2014-04-15
RU2533116C2 (ru) 2014-11-20
EP2401268A4 (en) 2013-01-02
RU2011139287A (ru) 2013-04-10

Similar Documents

Publication Publication Date Title
ZA201109522B (en) T cell receptors
GB0917094D0 (en) T-cell receptor
GB0917090D0 (en) T-cell receptor
EP2459581A4 (en) LIVER X RECEPTOR AGONISTS
EP2427430A4 (en) 5-OXO-ETE RECEPTOR ANTAGONIST COMPOUNDS
EP2517925A4 (en) SEAT DEVICE
GB0906157D0 (en) Improved wing structure
PL2513397T3 (pl) Zawias
EP2640246A4 (en) HINGE ARRANGEMENT FOR TOILET SEAT
IL216279A0 (en) Novel glucocorticoid receptor agonists
ZA201200641B (en) Sphingosine-1-phosphate receptor agonists
EP2566494A4 (en) CXCR4 RECEPTOR COMPOUNDS
HK1164318A1 (en) Oxyindole derivatives with motilin receptor agonistic activity
GB0917922D0 (en) Seat device
EP2344175A4 (en) METHODS OF SUPPRESSING THE ACTIVITY OF TOLL-LIKE RECEIVERS
EP2600887A4 (en) MICROCRYSTALLINE AGONISTS OF Y-RECEPTORS
EP2502627A4 (en) ANTI CANCER AGENTS
TWM373956U (en) Quick connection structure for hinge
TWM373957U (en) Hinge connection structure
TWM372596U (en) Fixing structure for monitor
GB0909723D0 (en) Hinge
PL2504512T3 (pl) Część zawiasowa
GB201200639D0 (en) Hinge
GB0909495D0 (en) T cell receptors
GB0911812D0 (en) T Cell receptors